MYELOID MALIGNANCIES
Clinical trials for MYELOID MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new MYELOID MALIGNANCIES trials appear
Sign up with your email to follow new studies for MYELOID MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for Tough-to-Treat blood cancers
Disease control CompletedThis early-stage study tested a new drug called PRT2527, both by itself and combined with other cancer drugs, in people with advanced blood cancers that had returned or stopped responding to standard treatments. The main goals were to find a safe dose and see if the treatments sh…
Matched conditions: MYELOID MALIGNANCIES
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Donor immune cells bolster transplant against blood cancer relapse
Disease control CompletedThis study tested whether adding 'off-the-shelf' natural killer (NK) immune cells from a donor could make stem cell transplants more effective for adults with high-risk forms of leukemia. The goal was to see if this combination was safe and could help prevent the cancer from comi…
Matched conditions: MYELOID MALIGNANCIES
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC